JBIO JBIO Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by JBIO in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about JBIO's accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is JBIO's accrued expenses and other liabilities?
- JBIO (JBIO) reported accrued expenses and other liabilities of $5.77M in Q1 2026.
- How has JBIO's accrued expenses and other liabilities changed year-over-year?
- JBIO's accrued expenses and other liabilities increased by 396.3% year-over-year, from -$1.95M to $5.77M.
- What is the long-term trend for JBIO's accrued expenses and other liabilities?
- Over 2 years (2022 to 2024), JBIO's accrued expenses and other liabilities has grown at a -33.6% compound annual growth rate (CAGR), from $3.98M to $1.75M.